Notes

A fund called Catalyst Research Only has no size and uses compact receipts. It originated from the PRE91108 archive. On 2026-09-13T14:16:15.771095+00:00, a news scan found the headline 'Tamboran Delivers First Gas Sales From the Beetaloo Basin' from TBNnews. Another news scan found a filing from CNXC with a filing date of 2026-08-14. A corporate calendar from Tamboran was also found. Additionally, a blog post from Neovolta was found, discussing home battery safety. Scholar Rock announced FDA approval of ISEMBYLD. A decision was made to exit SRRK and NEOV on certain dates, and a group includes SRRK, SCHL, PRAX, and others. The original update had 7 panels and a raw sha of 3e7dd96f316bd217fa9f743e43c5791dec2c9ff2bb4ee8b7598d7ba0b21877ef.

The Catalyst research fund has a size of 0 and was updated at 14:16:10 on September 13, 2026. The fund manager reviewed news from several companies, including Telix Pharma on September 10, 2026, which discussed reliable access to GA-68 radiopharmaceuticals. Mission Produce announced its fiscal 2026 third-quarter financial results on September 8, 2026. ABM reported its fiscal third-quarter 2026 results on September 8, 2026. Roivant announced positive results from the Phocus study of mosliciguat on September 8, 2026. The fund manager also reviewed filings from UNFI, DRI, PPIH, MRK, and WLTH. Evolution Petroleum declared a $0.12 per share cash dividend for fiscal Q1 on September 10, 2026. Innate Pharma filed a 6-K on September 10, 2026. The fund manager checked the websites of KGF, ASKUL, IPHA, and SOBI, and found that IPHA had an error. The fund manager will revisit IPHA on September 17 and review Sobi's receipt and Q1 2028 conditional statement. The fund manager will preserve monitors 165, 168, 167, 137, and 22. The sources and dates are listed in the job script and journal. No orders were placed.

A fund manager reviewed notes from the Catalyst research fund, which has a size of 0 and compact receipts. The notes originated from the PRE91108 archive and were last updated on 2026-09-13T12:01:38.781347+00:00. The manager found six panels of information, including a news headline from TBNnews about Tamboran delivering first gas sales from the Beetaloo Basin, a filing from CNXC, and announcements from NEOV and SRRK. The panels also included a corporate calendar from Tamboran and a blog post from Neovolta about home battery safety. The manager noted an exit from an SRRK/SCHL/PRAX group and a call exit from NEOV on September 22, as well as a planned event for TBN on September 25. The manager reviewed the original notes before taking action.

The Catalyst fund is currently in research mode only, with a size of 0, as of September 13, 2026, at 11:46:15 UTC. The fund is tracking several companies, including IONS, MIRM, GIS, and EAT. Recent SEC filings include IONS on September 4, MIRM on September 8, GIS on July 1, and EAT on August 12. A discovery was made on September 9 that Barclays maintains an overweight rating on Ionis Pharmaceuticals, but lowers its price target to $85. GIS has a conference scheduled for September 8, and its earnings report is set for September 23. The fund's strategy for GIS is to record and validate if its organic cash is strong, but to reverify if it is weak or absent. The baseline for GIS's FY27 EPS is $3.00-3.20, with organic growth expected to be between -1.5% and +0.5%, and savings of $750 million. EAT has an investor day scheduled for September 17, and its earnings call is set for October 28. The fund's strategy for EAT is to record and validate if its organic cash is strong, but to reverify if it is weak or absent. The fund has a frozen paper window from September 16 to September 21, and its calendar is out of sync by +0.567%. The fund's decisions are based on a set of rules, including verifying full pipelines and early news, and it does not make automatic trades. The fund's research is ongoing, with no orders currently in place, as of September 13, 2026, at 11:46:17 UTC.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 13, 2026, at 11:46:04 UTC. The fund manager reviewed the following SEC filings: CHWY on September 9, 2026, ASO on September 9, 2026, LOVE on September 10, 2026, and SFIX on July 28, 2026. The manager also reviewed the following RSS feeds: SAIL on September 9, 2026, KFY on September 9, 2026, and LOVE on September 10, 2026. Additionally, the manager checked the FDA website for information on GRAL, which has a meeting scheduled for September 23, 2026. The manager noted that the SEC filings may lag behind news and will review the following upcoming events: new morning results on September 9 at 12:30, LOVE results on September 10 at 12:30, SFIX results on September 24 at 12:30 after the September 23 AMC, and the GRAL panel on September 23, which is not an approval. The manager will use a strong cash position to record and validate results, and a weak or early position to cash and reverify. No automatic orders were placed.

The fund is called Catalyst Research and it is for research purposes only. The fund size is 0 and the time is 2026-09-13T10:16:00.121524+00:00 UTC. There are several news updates from various companies, including TLX on September 10, 2026, AVO on September 8, 2026, ABM on September 8, 2026, and ROIV on September 8, 2026. Additionally, there are financial reports from UNFI on September 8, 2026, DRI on July 24, 2026, PPIH on September 9, 2026, MRK on August 7, 2026, and WLTH on September 9, 2026. EPM announced a cash dividend on September 10, 2026, and IPHA filed a report on September 10, 2026. The HTTP status codes for KGF, ASKUL, and SOBI are 200, with hashes dda88bf6ef8ad805, e6f0d85c03a37ce6, and d719eca30b8a5a99, respectively. However, there was an error with IPHAnews due to a ValueError. The research will continue, with a focus on strong and new information, and a revalidation of weak or absent information. There are conditional receipts for IPHA on September 17 and Sobi for Q1-2028. The monitors for 165, 168, 167, 137, and 22 will be preserved. The sources and dates are listed in the job script and journal, and there are no orders at this time.

A fund manager's notes from the Catalyst research fund, which has a size of 0, were compacted into six primary receipts. The origins of these receipts are in the PRE91108 archive, and the update was made on 2026-09-13T10:01:14.188411+00:00. The notes include a news scan that found the headline 'Tamboran Delivers First Gas Sales From the Beetaloo Basin' from TBNnews on September 8, 2026. Another news scan found a filing from CNXC on August 14, 2026, which was a SCHEDULE 13G form. A corporate calendar from Tamboran was also referenced. Additionally, a news scan found the headline 'Scholar Rock Announces FDA Approval of ISEMBYLD' from SRRK on September 11, 2026. A blog post from Neovolta on home battery safety was also mentioned. The notes also include a decision to exit a position in NEOV on September 22 and another decision regarding TBN on September 25. These notes are a compilation of seven panels, each with a unique sha code, and are based on previews of the original data.

A fund manager's notes for the Catalyst Research fund, which has a size of 0, were compacted on 2026-09-13T09:01:10.448642+00:00. The notes include a list of panels with previews of various company updates and announcements. The panels mention companies such as HITI, BFRI, and PLAY, with links to their SEC filings and other relevant information. The notes also mention conferences and earnings calls for companies like EGTX. A news scan found the headline 'Dave & Buster’s Entertainment, Inc. to Report' on September 1, 2026. The notes also mention the lifting of a suspension by the ITC on September 1, 2026, for BFRI. The originals of these notes should be read before taking any action.

The Catalyst fund is currently researching the stocks IONS, MIRM, GIS, and EAT, as well as CAG, with a size of 0. As of September 13, 2026, at 07:46:02 UTC, the fund has noted the following: IONS filed a report with the Securities and Exchange Commission (SEC) on September 4, 2026, which can be found at https://www.sec.gov/Archives/edgar/data/874015/000114036126035802/ef20081690_8k.htm. MIRM filed a report with the SEC on September 8, 2026, which can be found at https://www.sec.gov/Archives/edgar/data/1759425/000175942526000047/mirm-20260902.htm. GIS filed a report with the SEC on July 1, 2026, which can be found at https://www.sec.gov/Archives/edgar/data/40704/000162828026046337/gis-20260701.htm. EAT filed a report with the SEC on August 12, 2026, which can be found at https://www.sec.gov/Archives/edgar/data/703351/000070335126000026/eat-20260810.htm. On September 9, 2026, at 13:12:14 UTC, Barclays maintained an overweight rating on Ionis Pharmaceuticals and lowered its price target to $85. GIS had a conference on September 8, 2026, at 19:00 UTC, which can be reviewed. The fund is waiting for the earnings report of GIS on September 23, 2026, at 13:00 UTC. If GIS has stronger organic cash flow, it will be recorded and validated, but if it is weaker or absent, the cash flow will be reverified. The baseline for GIS is an EPS of $3.00-3.20 for the fiscal year 2027, with an organic growth of -1.5% to +0.5% and savings of $750 million. The fund is also waiting for the investor day of EAT on September 17, 2026, at 08:30-11:15 CT, and the earnings call on October 28, 2026, at an unknown hour. If EAT has stronger organic cash flow, it will be recorded and independently validated, but if it is weaker or absent, the cash flow will be reverified. The fund has ended its review of four SEC reports, one discovery, two GIS reports, and two EAT reports, and will verify the full pipelines and early news.

A fund manager reviewed notes from the Catalyst research fund, which has a size of 0 and compact receipts. The notes originated from the PRE91108 archive and were last updated on 2026-09-13T07:46:06.375415+00:00. The manager reviewed six panels of information, including a news scan that found the headline 'Tamboran Delivers First Gas Sales From the Beetaloo Basin' from TBNnews on September 8, 2026, and a Securities and Exchange Commission filing from CNXC on August 14, 2026. The manager also reviewed announcements from Scholar Rock and Neovolt, and a list of groups including SRRK, SCHL, and PRAX. The manager made decisions to exit certain positions, including NEOV on September 22 and TBN on September 25.

The fund, named Catalyst, is for research only and has a size of 0. The current time is 2026-09-13T07:31:05.815920+00:00 UTC. The fund manager has reviewed the following SEC filings: CHWY on 2026-09-09, ASO on 2026-09-09, LOVE on 2026-09-10, and SFIX on 2026-07-28. The manager has also reviewed the following news releases: SAIL on September 9, 2026, KFY on September 9, 2026, and LOVE on September 10, 2026. Additionally, the manager has checked the FDA website for updates on GRAL, which has a meeting scheduled for September 23, 2026. The manager notes that SEC filings may lag behind news releases. The manager will review new results on the following dates: September 9 at 12:30 for morning results, September 10 at 12:30 for LOVE, and September 24 at 12:30 for SFIX after the September 23 AMC. The GRAL panel on September 23 is not for approval. The manager has decided to preserve cash, with a record and validation process for strong cash positions and a cash and re-verification process for weak, early, or absent positions. No automatic orders have been placed.

The fund is called Catalyst Research and it is for research purposes only. The fund size was checked at 0 UTC on 2026-09-13T06:01:28.969534+00:00. There are several news updates from various companies, including TLX on Thursday, September 10, 2026, which can be found at https://telixpharma.com/news-views/reliable-access-and-availability-of-ga-68-radiopharmaceuticals/, AVO on Tuesday, September 8, 2026, which can be found at https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-announces-fiscal-2026-third-quarter-financial, ABM on Tuesday, September 8, 2026, which can be found at https://abm.gcs-web.com/news-releases/news-release-details/abm-reports-fiscal-third-quarter-2026-results, ROIV on Tuesday, September 8, 2026, which can be found at https://investor.roivant.com/news-releases/news-release-details/roivant-announces-positive-results-phocus-study-mosliciguat, UNFI on September 8, 2026, with an 8-K filing at 0001020859-26-000022/unfi-20260903.htm, DRI on July 24, 2026, with a 10-K filing at 0000940944-26-000025/dri-20260531.htm, PPIH on September 9, 2026, with a 10-Q filing at 0001437749-26-029988/ppih20260731_10q.htm, MRK on August 7, 2026, with a 10-Q filing at 0000310158-26-000212/mrk-20260630.htm, WLTH on September 9, 2026, with an 8-K filing at 0001628280-26-061131/wlth-20260909.htm, and EPM on Thursday, September 10, 2026, which can be found at https://ir.evolutionpetroleum.com/news-releases/news-release-details/evolution-petroleum-declares-012-share-cash-dividend-fiscal-q1. Additionally, there are filings from IPHA on September 10, 2026, with a 6-K filing at 0001628280-26-061214/a260910_6k.htm. The HTTP status codes for KGF, ASKUL, IPHAnews, and SOBI are all 200, with hashes dda88bf6ef8ad805, e6f0d85c03a37ce6, 63c1ed7a93468887, and d719eca30b8a5a99, respectively. The research is ongoing, with a note to read originals and validate strong or new information, and to cash and reverify weak, absent, or error information. There is a note about IPHA on September 17, and a conditional note about Sobi receipt and Q1-2028. The monitors 165, 168, 167, 137, and 22 are to be preserved. The sources and dates can be found in the job script and journal. There are no orders.

The fund is called Catalyst Research and it is for research only. The fund size is 0. This information comes from the PRE91108 archive. The data was last updated on 2026-09-13 at 05:31:33. There are six panels of information. The first panel has 71 characters and a unique code of 2fbeade1f0a72b7c. A news scan found the headline 'Tamboran Delivers First Gas Sales From the Beetaloo Basin' on TBN news on September 8, 2026. The second panel has 736 characters and a unique code of 35b7328fdf758a56. It mentions a company called CNXC, which is a stock ticker, a code used to identify a stock, and a filing date of 2026-08-14. The third panel has 483 characters and a unique code of 9b319fcc0f6464f5. It talks about a company called NEOV and a blog post about home battery safety on September 9, 2026. The fourth panel has 2979 characters and a unique code of 20a893bcb14321a6. The fifth panel has 416 characters and a unique code of 6003fc75312f424f. It mentions a company called TBN and a corporate calendar event. The sixth panel has 1708 characters and a unique code of 12e6401865294936. It talks about a company called SRRK and FDA approval of a drug called ISEMBYLD on September 11, 2026. The seventh panel has 325 characters and a unique code of 6abd1fe877acb858. It mentions a decision to exit a trade on September 22 for a company called NEOV and a trade on September 25 for a company called TBN.

The Catalyst fund is for research only on IONS, MIRM, GIS, and EAT, with no orders, as of September 13, 2026, at 03:31:08 UTC. The fund size is 0. The following SEC filings were found: IONS on September 4, 2026, MIRM on September 8, 2026, GIS on July 1, 2026, and EAT on August 12, 2026. A discovery on September 9, 2026, at 13:12:14Z, reported that Barclays maintains an overweight rating on Ionis Pharmaceuticals and lowers its price target to $85. A conference for GIS was held on September 8, 2026, at 19:00 UTC. The company General Mills will release its earnings on September 23, 2026, at 13:00 UTC. For GIS, stronger organic cash flow and guidance will be recorded and validated, while weaker or absent results will require cash reverification. No automatic entry will be made, and the dates listed are for review, not first news. The baseline for GIS is a FY27 EPS of $3.00-3.20, with organic growth of -1.5% to +0.5% and savings of $750 million. A paper window was frozen from September 16 to September 21, with a calendar out-of-sample performance of +0.567% and stress of -2.405%. For EAT, an investor day was held on August 31, 2026, and an earnings call is scheduled for October 28, 2026. The company will be reviewed on September 17, 2026, at 16:30 UTC, and on October 28, 2026, at 16:30 UTC. The fund will verify full pipelines and early news for the four companies, with four SEC filings, one discovery, two GIS events, and two EAT events. The fund is for research only, with no orders, as of September 13, 2026, at 03:31:10 UTC.

A fund manager's notes from the Catalyst research fund, which has a size of 0, were compacted into six primary receipts. The origins of the notes are in the PRE91108 archive, and they were last updated on 2026-09-13T03:31:09.867517+00:00. The notes include information about several companies, including CNXC, which filed a SCHEDULE 13G form on 2026-08-14. There is also a news article from TBNnews about Tamboran delivering first gas sales from the Beetaloo Basin. Additionally, there are previews of announcements from NEOV and SRRK, including an FDA approval for ISEMBYLD. The notes also mention an exit strategy for Sep22 and a call for Sep23AMC/17ET. The previews are based on raw data with hashes, including 4038e8495fc620b6, 9b319fcc0f6464f5, and 9eec909a4b1ca0544d01b505d26b1c517872359d63899613a36f99fd282eb733.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 13, 2026, at 03:16:14 UTC. The fund reviewed the following SEC filings: CHWY on September 9, 2026, ASO on September 9, 2026, and LOVE on September 10, 2026. It also reviewed an 8-K filing from SFIX on July 28, 2026. Additionally, the fund looked at RSS feeds from SAIL on September 9, 2026, KFY on September 9, 2026, and LOVE on September 10, 2026. The fund also checked the FDA website for information on GRAL, which has a panel meeting scheduled for September 23, 2026. The fund will review new morning results on September 9 and 10, and SFIX results on September 24. The GRAL panel meeting is not for approval. The fund has a strong cash position, which will be recorded and validated, while weak or early positions will be cashed and reverified. No automatic orders were placed.

The Catalyst research fund has a size of 0 as of September 13, 2026, at 02:01:20 UTC. Recent news includes: TLX on September 10, 2026, about reliable access to GA-68 radiopharmaceuticals; AVO on September 8, 2026, about fiscal 2026 third-quarter financial results; ABM on September 8, 2026, about fiscal third-quarter 2026 results; ROIV on September 8, 2026, about positive results from the Phocus study of mosliciguat. There are also SEC filings from UNFI on September 8, 2026, DRI on July 24, 2026, PPIH on September 9, 2026, MRK on August 7, 2026, and WLTH on September 9, 2026. Additionally, EPM declared a $0.12 per share cash dividend on September 10, 2026, and IPHA filed a 6-K on September 10, 2026. The HTTP requests for KGF, ASKUL, IPHA news, and SOBI were successful, with hashes dda88bf6ef8ad805, e6f0d85c03a37ce6, 63c1ed7a93468887, and d719eca30b8a5a99, respectively. The fund manager notes to research IPHA by September 17 and Sobi receipt by Q1 2028, conditionally. The monitors for 165, 168, 167, 137, and 22 are to be preserved. There are no orders and the sources and dates are in the job script and journal. The fund manager advises to read originals and validate strong and new information, and to cash and reverify weak, absent, or error information.

A fund called Catalyst Research Only has six primary receipts to report. The fund size is 0. The receipts come from the PRE91108 archive. The report was made on 2026-09-13 at 01:31:13.020422+00:00. The report includes several panels of information. Panel 0 is a summary of the fund. Panel 1 discusses CNXC and its SCHEDULE 13G filing on 2026-08-14. Panel 2 mentions a news article from TBN on September 8, 2026, about Tamboran's first gas sales. Panel 3 talks about NEOV and a blog post on home battery safety from 2026-09-09. Panel 4 references TBN's corporate calendar. Panel 5 announces FDA approval of ISEMBYLD by Scholar Rock on September 11, 2026. Panel 6 discusses trading decisions, including exiting SRRK and NEOV on certain dates. The report consists of 7 panels and has a unique identifier.

A fund manager reviewed notes for the Catalyst Research fund, which has a size of 0 and compact receipts. The origins of the notes are in the PRE91108 archive, and the review was done on 2026-09-13T00:46:25.025460+00:00. The manager looked at various panels, including SEC filings for HITI on 2026-08-31 and BFRI on 2026-08-13. The manager also reviewed earnings reports, such as Dave & Buster's Entertainment, Inc. on September 1, 2026, and TSM on September 10, 2026. Additionally, the manager looked at reviews for EGTX, including conferences on September 11 and 16, 2026. The manager also checked the US International Trade Commission website for information on BFRI. A news scan found the headline 'BFRI ITC https://www.usitc.gov/photodynamic_therapy_systems_components_thereof' and another headline 'BFRI Sep1 ITC lifted028suspension: https://public-inspection.federalregister.gov/'. The review consisted of 11 panels, and the manager read the originals before taking action.

The Catalyst fund is currently in research mode only, with a size of 0, as of September 12, 2026, at 23:16:20 UTC. The fund is monitoring the following stocks: IONS, MIRM, GIS, and EAT, with additional consideration for CAG, and preserves 126 with an exit of 0. The fund has reviewed SEC filings for IONS on September 4, 2026, MIRM on September 8, 2026, GIS on July 1, 2026, and EAT on August 12, 2026. A discovery on September 9, 2026, found that Barclays maintains an overweight rating on Ionis Pharmaceuticals, lowering its price target to $85. GIS has a conference scheduled for September 8, 2026, at 19:00 UTC, and will release earnings on September 23, 2026, with a Q&A session at 13:00 UTC. The fund will review GIS's organic cash flow and guidance, with stronger results leading to record and validation, and weaker results leading to cash re-verification. The baseline for GIS is an EPS of $3.00-3.20 for FY27, with organic growth of -1.5% to +0.5%, and savings of $750 million. EAT has an investor day scheduled for September 17, 2026, and will release earnings on October 28, 2026, with a review scheduled for 16:30 UTC. The fund will review EAT's organic cash flow, with stronger results leading to record and independent validation, and weaker results leading to cash re-verification. The fund has a frozen paper window from September 16 to September 21, and will not retune past tests. The fund is in research mode only, with no orders, as of September 12, 2026, at 23:16:24 UTC.

A fund called Catalyst Research has no size and only compact receipts. It originated from the PRE91108 archive. On 2026-09-12 at 23:16:23, a record was made. A news scan found the headline 'Tamboran Delivers First Gas Sales From the Beetaloo Basin' on TBN news on September 8, 2026. Another news item mentioned CNXC, a stock ticker, with a filing date of 2026-08-14 for a SCHEDULE 13G form. A corporate calendar was found on the website of Tamboran. A blog post about home battery safety was found on the website of Neovolta, or NEOV, on 2026-09-09. Scholar Rock announced FDA approval of a product called ISEMBYLD on September 11, 2026. A decision was made to exit a call on September 22 for NEOV and on September 25 for TBN. This information comes from seven panels of data, which should be read in their original form before taking any action.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 12, 2026, at 23:01:28 UTC. The fund manager reviewed the following SEC filings: CHWY on September 9, 2026, ASO on September 9, 2026, and LOVE on September 10, 2026. The manager also reviewed an 8-K filing from SFIX on July 28, 2026. Additionally, the manager looked at news releases from SAIL, KFY, and LOVE, which were published on September 9 and 10, 2026. The manager also checked the FDA website for information on GRAL, which has a meeting scheduled for September 23, 2026. The manager noted that the SEC filings may not be up to date with the latest news. The manager will review the results of LOVE on September 10 at 12:30 and SFIX on September 24 at 12:30, after the market closes on September 23. The manager also noted that the GRAL meeting on September 23 is not an approval meeting. The manager emphasized the importance of strong cash positions and record validation, and weak or early positions require cash reverification. No automatic orders were placed.

The fund is called Catalyst Research and it has a size of 0 as of September 12, 2026, at 21:46:28 UTC. There are several news updates from various companies, including Telix Pharma on September 10, 2026, regarding reliable access to certain radiopharmaceuticals, Mission Produce on September 8, 2026, about their fiscal 2026 third-quarter financial results, ABM on September 8, 2026, about their fiscal third-quarter 2026 results, and Roivant on September 8, 2026, about positive results from a study. Additionally, there are SEC filings from UNFI on September 8, 2026, DRI on July 24, 2026, PPIH on September 9, 2026, MRK on August 7, 2026, and WLTH on September 9, 2026. Evolution Petroleum declared a $0.12 per share cash dividend on September 10, 2026. There are also HTTP status updates with hashes for KGF, ASKUL, IPHA news, and SOBI. The research is ongoing, with a note to read originals and validate strong or new information, and to cash and reverify weak, absent, or error information. There is a note about IPHA on September 17 and a conditional Sobi receipt for Q1 2028. Certain monitors, including 165, 168, 167, and 137, and 22, should be preserved. The sources and dates are in the job script and journal, and there are no orders.

The fund is called Catalyst Research and it is for research only. The size of the fund is 0. This information comes from the PRE91108 archive. On September 12, 2026, at 21:16:42, the following information was recorded. There are six panels of information. The first panel has 71 characters and a unique code, or sha, of ef6d41de7c40f7f6. The second panel has 483 characters and a sha of 9b319fcc0f6464f5, and it mentions a company called CNXC and a form called SCHEDULE 13G, which is a type of filing that companies make with the government. The third panel has 736 characters and a sha of 35b7328fdf758a56, and it mentions a news article from TBNnews about a company called Tamboran delivering its first gas sales. The fourth panel has 416 characters and a sha of 6003fc75312f424f, and it mentions an event on the corporate calendar of Tamboran. The fifth panel has 1708 characters and a sha of 12e6401865294936, and it mentions a company called Scholar Rock announcing FDA approval of a product called ISEMBYLD. The sixth panel has 2979 characters and a sha of 20a893bcb14321a6, and it mentions a company called Neov and a blog post about home battery safety. The seventh and final panel has 325 characters and a sha of 6abd1fe877acb858, and it mentions several companies, including SRRK and NEOV, and some investment decisions, including an exit on September 22 and a call on September 23. These panels are a preview, and it is recommended to read the originals before taking any action.

A fund manager reviewed notes from the Catalyst research fund, which has a size of 0 and compact receipts. The notes originated from the PRE91108 archive and were last updated on 2026-09-12T19:16:05.811325+00:00. The manager reviewed six panels of information, including a news headline from TBNnews about Tamboran delivering first gas sales from the Beetaloo Basin, a filing from CNXC, and announcements from NEOV and SRRK. The manager also considered a list of groups, including SRRK, SCHL, and PRAX, and made decisions about exits, including exiting NEOV on September 22 and TBN on September 25.